Colorado BioScience Association

10/07/2026

A huge round of applause for our Nasdaq Tower moment.

It opened a dynamic Capital Perspectives Luncheon: From Private Capital to Public Markets. With close to 50 vetted, investor-ready presenting companies at CBSA's Rocky Mountain Life Sciences Investor & Partnering Conference Presented by BioMed Realty, the conversation focused on the capital environment they are navigating today and how companies can prepare for opportunities ahead.

CBSA Board of Directors Chair Byron Hewett highlighted state support for life sciences companies and provided an overview of CBSA's work on the comprehensive Colorado Life Sciences Strategic Roadmap, to be released in 2027.

Bradley Wolff of Evercore joined Marc Graboyes of Foley Hoag LLP, who serves on the CBSA Board of Directors, for a fireside chat on the current life sciences market, what is driving the deal cycle, and what founders and investors should be watching.

Marc then moderated a panel spanning private capital, public markets, and strategic investment with Alexander Porter, Nasdaq; Chau Khuong, CJNV BioVentures; Mike Clouthier, Medtronic; Dan Lyons, Ph.D., Janus Henderson; and Abby Mueller, J.P. Morgan Private Capital.

One theme surfaced throughout the conversations: relationships matter, and the strongest ones often develop well before a company prepares for an initial public offering. For founders and leadership teams, building those relationships over time gives investors and strategic partners an opportunity to understand the science, follow the company’s progress, and see how the team executes.

The luncheon concluded with a look at Colorado's leadership in innovation industries. CBSA President & CEO Elyse Blazevich joined Massimo Ruzzene, Senior Vice Chancellor for Research and Innovation at University of Colorado Boulder, to discuss Colorado’s leadership in quantum and the convergence of quantum technologies and life sciences.

Their conversation explored the depth of Colorado’s research assets, the work underway to move quantum technologies from lab to market, and the potential for convergence to create new opportunities in life sciences. It is one example of the distinctive combination of research, talent, companies, and infrastructure that sets Colorado apart as a place to build and grow.

Thank you to Bradley, Marc, Alex, Abby, Chau, Daniel, Mike, and Massimo for sharing their perspectives, and to Foley Hoag, J.P. Morgan, and Nasdaq for sponsoring the Capital Perspectives Luncheon. And a special thank you to Alex Porter and the team at Nasdaq for highlighting the Rocky Mountain Life Sciences Investor & Partnering Conference on the Nasdaq Tower.

Expanding access to capital is central to CBSA’s work. Bringing investors, strategic partners, and companies together in Vail gives relationships room to develop and creates new opportunities for Colorado and the Rocky Mountain West.

10/06/2026

We are remembering Brooke Eby, who passed away on October 1 at age 37, with gratitude for the humor, honesty, and urgency she brought to ALS advocacy. 💙

Diagnosed with amyotrophic lateral sclerosis (ALS) at 33, Brooke shared her experiences with candor and humor, reaching millions and building a community through her online support network, ALS Together. She was named the ALS Network’s 2026 Advocate of the Year.

At CBSA’s 21st Annual Awards Celebration in 2024, Brooke joined our President & CEO, Elyse Blazevich, for a conversation that made us laugh, moved us, and challenged us to “work at the speed of ALS.” Her words and her spirit have stayed with our community.

Our hearts are with Brooke’s family, friends, and everyone she brought together.

10/05/2026

For many people in the room during our Championing Women’s Health Breakfast, the memories came right back. During the 1996 Olympic Games, gymnast Shannon Miller faced incredible pressure, and executed flawlessly as she led the “Magnificent Seven” to the U.S. women’s first-ever team Gold.

That same persistence and determination carried Shannon through ovarian cancer and now guide her work as Founder & CEO of Salto Health. At last week’s Rocky Mountain Life Sciences Investor & Partnering Conference in Vail, she reminded attendees what it takes to keep going in the face of adversity: get up, do the work, and draw strength from the people around you.

That patient perspective opened a morning focused on opportunity:
• Company presentations: The Women’s Health Track featured women’s health technologies, alongside female-founded and female-led companies.
• Investment opportunities: The program highlighted Colorado-based AOA Dx and its “Follow the Exits” report, which identified more than $100 billion in realized value across women’s health exits.
• A connected community: Fourteen presenting companies included current or alumni members of CBSA’s Women’s Mastermind Group, which strengthens relationships and supports access to capital for female founders and leaders.

Shannon’s story brought us back to the purpose behind our work: earlier detection, better treatments, and innovations that give patients and families more options and hope. It opened a morning of presentations featuring women’s health technologies, and female-founded and female-led companies at the Rocky Mountain Life Sciences Investor & Partnering Conference Presented by BioMed Realty.

Thank you, Shannon, for sharing your experience with such warmth and candor. Thank you to breakfast sponsors Arnold & Porter, Biodesix, Inc., and Medtronic, and to Robin Harper Cowie of Biodesix, who serves as CBSA Board of Directors Vice Chair, for her heartfelt introduction.

We also thank Michael Mestek of Medtronic, Carlyn Williams of Arnold & Porter, and Brie Martin of conference Presenting Sponsor BioMed Realty for their remarks and commitment to our community.

More conference insights, photos, and videos are coming. Follow along here as we share the highlights.

10/02/2026

What an incredible three days in Vail! Thank you to our presenting companies, investors and strategic partners, sponsors, attendees, and regional partners. You made year’s Rocky Mountain Life Sciences Investor & Partnering Conference Presented by BioMed Realty one for the record books.

A high-energy Welcome Reception, sponsored by Terumo Blood and Cell Technologies and Questco Companies, kicked off the conference. Attendees enjoyed reconnecting and building new relationships on a beautiful fall evening in Vail.

Many highlights to come! Look for more insights, photo and video in the coming days.

10/01/2026

From the world’s financial capital to the Rockies.

The Rocky Mountain Life Sciences Investor & Partnering Conference, presented by BioMed Realty, is underway in Vail after a bright moment on the Nasdaq Tower in Times Square!

Investors, partners, and close to 50 vetted, investor-ready companies are coming together to build relationships, explore opportunities, and advance health innovation.

Thank you, Alexander Porter and Nasdaq, for shining a spotlight on our conference and the incredible presenting companies from our region.

09/24/2026

We’re less than one week away from CBSA's 2026 Rocky Mountain Life Sciences Investor & Partnering Conference Presented by BioMed Realty, September 30–October 2 in Vail.

A record group of attendees will join us in Vail, including close to 50 vetted, investment-ready companies will present opportunities across biotech, pharma, medical device, diagnostics, digital health, animal health, and ag bio.

The conference brings together investors, strategic partners, founders, and company leaders to build new connections, exchange ideas, and advance the growth and impact of health innovation across Colorado and the Rocky Mountain West. General registration is sold out. Qualified investors may still apply for complimentary registration.

Investor Registration Form: https://cobioscience.com/investor-survey/

Learn more: https://cobioscience.com/networking-events/rocky-mountain-life-sciences-investor-partnering-conference/

09/16/2026

Please join us in welcoming Alex Delaney to Colorado BioScience Association as our new Member Success Manager.

Alex brings experience spanning entrepreneurship, technology consulting, and nearly a decade of nonprofit leadership focused on mentorship, youth advocacy, and community engagement. Most recently, he served as Director of Coaching for Colorado Rapids Youth Soccer Club.

At CBSA, Alex will focus on delivering outstanding value for our members and sponsors. He will lead member onboarding, strengthen the overall member experience, help members make the most of their CBSA benefits and connections, and oversee event operations across our programs and signature events.

We’re pleased to welcome Alex to the team and look forward to introducing him to members across Colorado’s life sciences ecosystem.

Meet the CBSA Team:
https://cobioscience.com/meet-cbsa/our-team/

09/11/2026

Colorado stands out for its convergence across innovation industries, including life sciences, quantum, space, advanced sensing, and other high-growth sectors.

On September 17, CBSA President & CEO Elyse Blazevich will join leaders from Elevate Quantum, the Colorado Space Coalition, and the NSF ASCEND Engine for a fireside chat at Innosphere’s Innovation After Hours, following a keynote from the Milken Institute.

Together, they’ll explore how Colorado’s research strengths, highly skilled talent, advanced technologies, and collaborative culture create opportunities to accelerate discovery, attract investment, and grow companies.

📅 Thursday, September 17 | 4:00–5:40 p.m. MT
📍The Legacy Building at the National Western Center, Denver

Register: https://lp.constantcontactpages.com/ev/reg/3x9nvuq/lp/8a74dc36-f510-4abb-9b96-399389f83179

The Milken Institute, author of the Best Performing Cities report, headlines Innosphere's flagship Innovation After Hours this September at The Legacy Building, sponsored by FBT Gibbons. Hundreds of Colorado's economic leaders will gather as Milken delivers a data-driven keynote benchmarking our sta...

09/03/2026

Members in the news: The Colorado Sun highlights Terumo Blood and Cell Technologieso Blood and Cell Technologies and the company's six decades of history in our state. The article provides details on a new, two-year program that immerses employees on all aspects of the company's supply chain.

Terumo employs more than 1,600 of Colorado's life sciences professionals at its global headquarters in Lakewood and its state-of-the-art manufacturing facility in Littleton.

Article: https://coloradosun.com/2026/08/22/colorado-job-growth-hiring-alternatives/

Learn more about Terumo Blood and Cell Technologies and more leading more leading life sciences companies, innovation communities, and academic and research institutions in our video from CBSA's Drive to Five: Colorado Life Sciences Innovation Tour.

09/02/2026

Join CBSA on September 10 for Thought Leadership Series: Navigating Reimbursement, an interactive discussion designed to help companies strengthen their approach to:

• Payer engagement

• Coding, coverage, and payment pathways

• Market access planning

• Reimbursement strategy across development stages

For life sciences founders and executive teams, addressing those questions early can strengthen investor readiness and inform smarter development decisions.

The program is designed for biotech, pharma, medical device, diagnostics, and digital health companies, along with investors and strategic partners.

🗓️ Thursday, September 10 | 2:00–6:00 p.m. MT

📍 Polsinelli | Denver

This high-value event, sponsored by Polsinelli, is complimentary for CBSA Members. It will be time well spent! Please consider joining us.

Register Now: https://events.cobioscience.com/en/fk3ZBIM7/thought-leadership-series-navigating-reimbursements-5a2HVulcIld/overview